#NephJC

Harish Seethapathy

BetterCallSeeth

Fun fact about this study which highlights a quirk of our fellowship program @MGHKidneys @BWHKidney For those who do not know, our 1st year of fellowship is split equally between

Swapnil Hiremath, MD, MPH

Next up The Ri-Cyclo trialVitamin R vs old and trusted cyclophosphamide in membranousWho will win? #KidneyWk #LBCT ePoster 17 RI-CYCLO eligibility:GFR > 30Proteinuria > 3.5 g/day#LBCT eposters at #KidneyWk Intervention

Swapnil Hiremath, MD, MPH

Up next at #ESCCongress is the BRACE-CORONA trial from Brazil on continuing or stopping ACE/ARBs in COVID-19https://clinicaltrials.gov/ct2/show/NCT043648931/ why does it matter? see the #NephJC background on the topic here -

Swapnil Hiremath, MD, MPH

Others may have made fun of this ridiculous foray from the @nytimes into guidelines But let’s quickly look at 2 related to the kidneys (H/t @edclark75 for pointing out this

Dr. Vida Vakilotojar

If COVID19 virus uses ACE2 receptors on lung cells to invade them, cannot (synthetic) ACE2 be used in an inhaler to protect against the virus? The inhaled ACE2 would deactivate

Sudha Mannemuddhu

Visual abstract (VA), seems to be a rising star in this new #meded & #FOAM eraMany journals are adopting VACool clubs like #NSMC, #NephJC uses VAHow about we discuss creating

SGLT2 Inhibitors as Diuretics:Tweetorial SGLT2i: how is it’s diuretic effect potentially different from the Loop Diuretics?1/@RenalFellowNtwk @NephJC#NephJC #SGLT2i Let’s start with a Poll:Loop Diuretics inhibit the Tubuloglomerular Fe

Anand Jagannath

My team recently asked WHY we give Fe to pts with HFrEF+anemia. First answer: b/c someone told me soBetter answer: let me get back to you on thatLet’s explore and